IEX Stock Recent News

NORTHBROOK, Ill.--(BUSINESS WIRE)--IDEX Corporation (NYSE:IEX) announced today that it has scheduled the broadcast of the company's third quarter earnings conference call over the internet on Thursday, October 26, 2023 at 9:30 a.m. CT. Chief Executive Officer and President Eric Ashleman and Interim Chief Financial Officer Allison Lausas will discuss the company's third quarter financial performance, and respond to questions from the financial community. IDEX invites interested investors to list.

Investors looking for stocks in the Manufacturing - General Industrial sector might want to consider either Standex International (SXI) or Idex (IEX). But which of these two stocks is more attractive to value investors?

Increasing costs, forex woes and weakness in the HST segment due to inventory destocking in the biopharma and semiconductor end markets are weighing on IDEX's (IEX) performance.

Investors interested in Manufacturing - General Industrial stocks are likely familiar with Standex International (SXI) and Idex (IEX). But which of these two stocks presents investors with the better value opportunity right now?

On July 27, 2023, IDEX Corp ( IEX , Financial) recorded a daily gain of 3.23%, with an Earnings Per Share (EPS) (EPS) of 7.72. This article aims to explore the question: Is IDEX Corp (IEX) modestly undervalued?

IDEX Corporation (NYSE:IEX ) Q2 2023 Earnings Call Transcript July 27, 2023 10:30 AM ET Company Participants Allison Lausas - VP & CAO Eric Ashleman - CEO, President & Director William Grogan - CFO & SVP Conference Call Participants Michael Halloran - Robert W. Baird & Co. Deane Dray - RBC Capital Markets Allison Poliniak - Wells Fargo Securities Vlad Bystricky - Citigroup Joe Giordano - TD Cowen Nathan Jones - Stifel, Nicolaus & Company Robert Wertheimer - Melius Research Operator Greetings and welcome to the IDEX Corporation Earnings Conference Call Second Quarter 2023.

IDEX's (IEX) Q2 earnings results reflect gains from solid segmental performances. However, the company lowered its earnings guidance for 2023.

While the top- and bottom-line numbers for Idex (IEX) give a sense of how the business performed in the quarter ended June 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Idex (IEX) came out with quarterly earnings of $2.18 per share, beating the Zacks Consensus Estimate of $2.12 per share. This compares to earnings of $2.02 per share a year ago.

Softness across pharma, biopharma and nutrition end markets within the material processing technology business is likely to have hurt IDEX's (IEX) Q2 performance.